February 5 (SeeNews) - Slovenian drug maker Krka [LJE:KRKG] said on Wednesday the Oslo court of appeals has found its Swedish subsidiary, Krka Sverige, in breach of a patent for proton pump inhibitor esomeprazole with high optical purity.